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Abstract
An optimal dynamic treatment regime (DTR) consists of a sequence of decision
rules in maximizing long-term benefits, which is applicable for chronic diseases such
as HIV infection or cancer. In this paper, we develop a novel angle-based approach
to search the optimal DTR under a multicategory treatment framework for survival
data. The proposed method targets maximization the conditional survival function of
patients following a DTR. In contrast to most existing approaches which are designed
to maximize the expected survival time under a binary treatment framework, the pro-
posed method solves the multicategory treatment problem given multiple stages for
censored data. Specifically, the proposed method obtains the optimal DTR via in-
tegrating estimations of decision rules at multiple stages into a single multicategory
classification algorithm without imposing additional constraints, which is also more
computationally efficient and robust. In theory, we establish Fisher consistency of
the proposed method under regularity conditions. Our numerical studies show that
the proposed method outperforms competing methods in terms of maximizing the
conditional survival function. We apply the proposed method to two real datasets:
Framingham heart study data and acquired immunodeficiency syndrome (AIDS) clin-
ical data.
Key words: Classification; Inverse probability weighting; Kaplan-Meier estimator; Out-
come weighted learning; Precision medicine; Survival function.
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1 Introduction
Precision medicine tailored for individuals has become an important strategy in treating
chronic diseases and conditions of patients. Dynamic treatment regimes (DTR) play a
central role in precision medicine, such as recommendation of optimal treatments to indi-
vidual patients according to patients’ previous treatments and medical histories. A DTR is
also called an adaptive intervention (Collins et al. 2004), or adaptive strategy (Lavori and
Dawson 2000) under other contexts. In practice, an effective treatment strategy should
not focus on short-term benefits, but aim for the most favorable long-term benefits. Con-
sequently, the goal is to seek an optimal DTR, which is defined as a sequence of decision
functions, to maximize the expected long-term benefits (Murphy 2003, 2005).
For chronic diseases such as cancer or HIV infection, survival time is often the outcome
of interest, and developing an optimal DTR is critical under the survival data framework.
Although many existing works have made important contributions to the estimation of
the optimal DTR (Watkins and Dayan 1992, Murphy 2003, 2005, Chakraborty et al. 2010,
Moodie and Richardson 2010, Robins et al. 2008, Zhang et al. 2013, Zhao et al. 2015, Zhu
et al. 2017, Robins et al. 2000, Blatt et al. 2004), very few works focus on maximizing
survival probability. Yet, maximizing survival probability is also vital for patients. There
are two main challenges in estimating the optimal DTR for censored data. The first one is
that there could be a lack of treatment and covariate information from patients in follow-up
stages due to censoring. The second one is that the true survival time might be unknown for
patients who are still alive at the censoring time (Goldberg and Kosorok 2012). Methods
proposed by Zhao et al. (2011), Jiang et al. (2017), Bai et al. (2017), Huling and Yu (2018),
Zhao et al. (2014), Hager et al. (2018) only focus on one or two decision points (stages),
while the censored Q-learning algorithm (Goldberg and Kosorok 2012) and the stabilized
O-learning approach (Zhao et al. 2018) are able to deal with settings including more than
two stages.
Nevertheless, none of the aforementioned methods can handle multicategory treatment
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scenarios when constructing a DTR. Two common approaches to solving multicategory
classification problems are one-versus-one and one-versus-rest approaches (Allwein et al.
2000), which both apply sequential binary classifiers. However, the sequential binary clas-
sifier only yields a sub-optimal result in some cases (Zhang and Liu 2013). Another ap-
proach to consider multiple treatment choices simultaneously is to estimate a classification
function vector with a dimension determined by the number of category (Crammer and
Singer 2001, Hastie et al. 2009, Liu and Yuan 2011, Vapnik and Vapnik 1998). The corre-
sponding decision rule assigns a subject to the category with the largest estimated value
in the classification function vector for this subject. Typically, a sum-to-zero constraint,
requiring the sum of values from the classification function vector to be zero, is used to
reduce the parameter space for desirable theoretical properties (Lee et al. 2004, Liu and
Yuan 2011). However, additional computational cost is needed to solve the constrained
optimization problem which could be inefficient (Zhang and Liu 2014).
To overcome these drawbacks, Zhang and Liu (2014) proposed an angle-based large-
margin classifier, which can significantly reduce the computational cost without additional
constraints, and outperforms other standard classification methods. To adapt this tech-
nique to precision medicine, Zhang et al. (2018) formulated a weighted angle-based method
to develop an individualized treatment rule with multiple treatment choices. Tao and
Wang (2017) proposed an adaptive contrast weighted learning method to identify the op-
timal DTR in a multicategory treatment setting. However, those approaches are neither
applicable for multiple decision points nor can they handle censored outcomes.
In this paper, we propose a new angle-based weighted approach for estimation of the
optimal DTR by maximizing the conditional survival probability under a multicategory
treatment framework. Specifically, we propose a weighted Kaplan-Meier (KM) estima-
tor to estimate the survival function under a DTR through the inverse of the treatment
probability at each stage. One key idea is to decompose the survival function at a given
time-point to a product of survival probabilities at time-points before the given time. An
advantage of this decomposition is that we only need to consider treatments received at
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stages before each of these previous time-points, since the survival probability at a certain
time cannot be affected by treatments received later than that time. In this way, we can
incorporate all available observations from patients into a weighted KM estimator, even
though some patients may lack treatment and covariate information at certain stages due
to censoring. In addition, we adopt an angle-based classifier to consider multiple potential
treatment choices simultaneously and avoid the sum-to-zero constraint, which could be
computationally restrictive in optimization.
Moreover, we propose to estimate decision rules for all stages simultaneously by maxi-
mizing the proposed objective function over a class of treatment regimes. In other words,
our method integrates the estimations of decision rules at multiple stages as one joint
weighted multicategory classification problem. This simultaneous procedure enables our
approach to be more robust by circumventing potential model-misspecification problems
arising in the Q-learning approaches, which recursively fit posited regression models based
on the estimations of regression models at future stages (Zhao et al. 2015, Zhou and Kosorok
2017).
The main contributions of this paper can be summarized as follows. First, to the best
of our knowledge, this is the first work which directly estimates the optimal DTR under a
multicategory treatment framework for censored data. Second, the proposed method max-
imizes the survival probability in searching an optimal DTR with more than two decision
stages. This has a profound impact in practice, since there is a high demand from long-term
treatment management for making multistage decisions in treating chronic diseases. Third,
the proposed method transforms DTR estimation problems at multiple stages into a joint
multicategory classification problem and solves the optimization problem without imposing
additional constraints, which improves computational efficiency and avoids potential over-
fitting problems. In theory, we establish Fisher consistency of the proposed method, which
has not previously been established for the estimation of DTR under the multicategory
treatment framework.
The remainder of the paper is organized as follows. In Section 2, we introduce the
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background and notation of the DTR and survival analysis. In Section 3, we propose an
angle-based weighted Kaplan-Meier estimator for the conditional survival function under a
DTR. Based on this estimator, we propose a novel estimation approach for the optimal DTR
under the multicategory treatment framework. The Fisher consistency of the proposed
method is established in Section 4. The computation algorithm is provided in Section 5.
In Section 6, we present empirical comparisons of the proposed method with the censored
Q-learning and subgroup identification method. Section 7 illustrates the application of
the proposed method for the Framingham Heart data and AIDS clinical data. Finally, we
conclude with discussion in Section 8.
2 Background and notations
In this section, we introduce background and notations for the standard dynamic treatment
regime setting and survival analysis. We assume that the observed data are
{(Xi1, Ai1, . . . ,Xim(Yi), Aim(Yi), Yi)}ni=1,
containing n independent, identically distributed samples of (X1, A1, . . . ,Xm(Y ), Am(Y ),
Y ), whereXm ∈ Rp denotes the covariates information collected between the (m−1)-th and
m-th stages, Am ∈ A denotes the treatment assigned at the m-th stage, Y = T ∧C denotes
the observed survival time, and T and C correspond to the survival time and censoring
time, respectively. Here, m(t) represents the index of the stage where the time-point t
belongs, implying that a subject is either censored, or a failure event occurs at the stage
m(Y ). In addition, we let ∆ = I(T ≤ C) be an indicator for the occurrence of the failure
event at or before the censoring time, and let A˜m = (A1, . . . , Am) and X˜m = (X1, . . . ,Xm)
be longitudinal combinations of treatments and covariates from the first stage to the m-
th stage, respectively. Let Hm = (X˜m, A˜m−1) denote accrued information up to the
m-th stage in which H1 = X1. Throughout this paper, we make the non-informative
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censoring assumption that the censoring time C is independent of survival time, covariates
and treatments; that is, the censoring is random and non-informative.
For a given time-point tg, our goal is to find a sequence of decision rules D˜mg(Hmg) =
{D1(H1), . . . ,Dmg(Hmg)} under which the survival function at tg
SD˜mg (tg) = E1
[
ED˜12
[
· · ·ED˜mg−1mg
[
P{T > tg|X˜mg , A˜mg = D˜mg(Hmg)}
]
· · ·
]]
= E1
[
ED˜12
[
· · ·ED˜mg−1mg
[
E{I(T > tg)|X˜mg , A˜mg = D˜mg(Hmg)}
]
· · ·
]]
, (2.1)
is maximized, where E1 and E
D˜m−1
m represent expectations with respect to X1 and {Xm |
X˜m−1, A˜m−1 = D˜m−1(Hm−1)}, respectively, for 2 ≤ m ≤ mg. Here, mg = m(tg−1) since
the survival probability at time tg is assumed to only be affected by treatments at or before
time tg−1.
3 Angle-based weighted Kaplan-Meier method
3.1 Survival function under a sequence of decision rules
To estimate an optimal DTR which maximizes the SD˜mg (tg) in (2.1), we first derive a
weighted Kaplan-Meier estimator for the survival function SD˜mg (tg) as follows. Let ED˜mg
denote the expectation with respect to distribution PD˜mg , which is the conditional distri-
bution of (T,Hm(t), Am(t)) under A˜m(t) = D˜m(t)(Hm(t)) with probability density function
p(T |Hmg , Amg)I[A˜mg = D˜mg(Hmg)]
mg∏
j=1
p(Xj|Hj−1, Aj−1), (3.1)
where p(X1|H0, A0) = p(X1).
Since the censoring is random and able to occur at any time-point before tg, we adopt
the Kaplan-Meier estimator to decompose the survival probability SD˜mg (tg) in terms of
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survival probabilities at time-points before tg, and estimate S
D˜mg (tg) as:
SD˜mg (tg) = ED˜mg [I(T > tg)] =
g∏
s=1
qD˜mg (s), (3.2)
where
qD˜mg (s) =
ED˜mg [I(T ≥ ts+1)]
ED˜mg [I(T ≥ ts)]
. (3.3)
Note that the occurrence of a failure event before or at a specific time ts can only be
affected by the treatments and covariates before ts. We assume that
I(T = ts or T ≥ ts) ⊥⊥ Z | {X˜m(ts−1), A˜m(ts−1) = D˜m(ts−1)
(
Hm(ts−1)
)}, (3.4)
where Z represents Xm or Am = Dm(Hm) for m > m(ts−1). Under the above assump-
tion, we can ignore the influence of the treatments after the m(ts−1)-th stage, and the
corresponding modified qD˜mg (s) is
qD˜mg (s) = 1− E
D˜mg [I(T = ts)]
ED˜mg [I(T ≥ ts)]
= 1− E
D˜m(ts−1) [I(T = ts)]
ED˜m(ts−1) [I(T ≥ ts)]
. (3.5)
However, samples from the distribution PD˜mg with the density in (3.1) are generally
not observable, which implies that ED˜m(ts−1) [I(T ≥ ts)] cannot be calculated based on the
observed data directly. To estimate qD˜mg (s), we convert the expectation ED˜m(ts−1) to an
unconditional expectation using the Radon-Nikodym theorem. That is,
ED˜m(ts−1) [I(T ≥ ts)] =
∫
I(T ≥ ts)dPD˜m(ts−1) =
∫
I(T ≥ ts)dP
D˜m(ts−1)
dPm(ts−1)
dPm(ts−1), (3.6)
where Pm(ts−1) denotes the unconditional distribution of (T,Hm(ts−1), Am(ts−1)) with the
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following probability density function
p(T |Hm(ts−1), Am(ts−1))
m(ts−1)∏
j=1
p(Aj|Hj)p(Xj|Hj−1, Aj−1).
Since
dPD˜m(ts−1)
dPm(ts−1)
=
I[A˜m(ts−1) = D˜m(ts−1)(Hm(ts−1))]∏m(ts−1)
j=1 p(Aj|Hj)
,
the Radon-Nikodym derivative dPD˜m(ts−1)/dPm(ts−1) exists under the positivity assumption
that p(Aj|Hj) > 0 for all 1 ≤ j ≤ m(ts−1). Thus, the expectation ED˜m(ts−1) in (3.6) can be
expressed as an unconditional one:
ED˜m(ts−1) [I(T ≥ ts)] = E
{
I[A˜m(ts−1) = D˜m(ts−1)(Hm(ts−1))]
p(A˜m(ts−1)|Hm(ts−1))
I(T ≥ ts)
}
, (3.7)
which incorporates the inverse weighting of the treatment probability p(A˜m(ts−1)|Hm(ts−1)).
This probability appears in randomized clinical trials or must to be estimated in observa-
tional studies. Similarly, we have
ED˜m(ts−1) [I(T = ts)] = E
{
I[A˜m(ts−1) = D˜m(ts−1)(Hm(ts−1))]
p(A˜m(ts−1)|Hm(ts−1))
I(T = ts)
}
. (3.8)
To avoid unobserved confounders for the survival time and treatments, we assume that,
given Hm(ts−1), the potential outcomes of I(T = ts) and I(T > ts) are independent of
A˜m(ts−1), which is also a common assumption in inverse probability weighting approaches.
However, the survival time T in (3.7) and (3.8) is not fully observed due to censoring.
In practice, only the Y = T ∧C is observed. Note that we have assumed that the censoring
time C is independent of (T, A˜m, X˜m) in Section 2. In fact, this assumption is standard in
clinical trials with several follow-up studies (Jiang et al. 2017). Under this non-informative
censoring assumption, we can substitute the unobserved survival time T with the observed
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Y by
qD˜mg (s) =
ED˜m(ts−1) [I(T = ts)]E[I(C ≥ ts)]
ED˜m(ts−1) [I(T ≥ ts)]E[I(C ≥ ts)]
=
E{I[A˜m(ts−1) = D˜m(ts−1)(Hm(ts−1))]I(Y = ts)∆/p(A˜m(ts−1)|Hm(ts−1))}
E{I[A˜m(ts−1) = D˜m(ts−1)(Hm(ts−1))]I(Y ≥ ts)/p(A˜m(ts−1)|Hm(ts−1))}
.
Consequently, we can estimate the survival probability SD˜mg (tg) with the observed data.
That is,
S¯D˜mg (tg) =
g∏
s=1
q¯D˜mg (s)
=
g∏
s=1
{
1−
∑N
i=1 w¯i(s− 1)I(Yi = ts)∆i∑N
i=1 w¯i(s− 1)I(Yi ≥ ts)
}
, (3.9)
where
w¯i(s) =
I[A˜im(ts) = D˜m(ts)(Him(ts))]
p̂(A˜im(ts)|Him(ts))
, (3.10)
and p̂(A˜im(ts)|Him(ts)) is an estimator of p(A˜im(ts)|Him(ts)), which depends on the number
of possible treatment choices and can be estimated through a penalized multinomial model
in Section 5.
One crucial component of the proposed method is decomposing the survival function in
terms of survival probabilities at time-points before the given tg as in (3.9). This strategy
allows us to only consider treatments received at stages before these time-points. Thus, we
can incorporate all available information from patients who are subject to censoring even
before the given tg. In addition, our method integrates the estimations of decision rules at
multiple stages together instead of recursively fitting the regression model at each stage,
which is more robust to model-misspecification.
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3.2 Multicategory dynamic treatment regimes
Although many developments have been made in estimation of the optimal DTR for binary
treatments, few existing approaches can handle multicategory treatments. In fact, the
extension from binary treatment choices to multicategory treatments is nontrivial. For
example, one can use a sequential binary classifier such as the one-versus-rest approach,
but this could lead to inconsistent estimation (Zhang et al. 2018). In addition, it is difficult
to make multicategory treatment comparisons efficiently (Tao and Wang 2017).
To overcome these difficulties, we propose an angle-based weighted Kaplan-Meier method
to obtain the optimal DTR D˜∗mg , such that SD˜
∗
mg (tg) ≥ SD˜mg (tg) for all sequential rules
D˜mg under the multicategory treatment framework. We adopt an angle-based classifi-
cation (Zhang and Liu 2014) idea to incorporate multicategory treatments. Under the
multicategory DTR framework, there are K possible treatments. To visualize the K pos-
sible treatments from a geometric perspective, we define a simplex V with K vertices
(V1, ...Vj, ...,VK) in a (K − 1)-dimensional space such that
Vj =

1√
K−11K−1, j = 1,
− 1+
√
K
(K−1)3/21K−1 +
√
K
K−1ej−1, 2 ≤ j ≤ K,
where 1K−1 is a vector of 1’s with a length of K − 1, and ej ∈ RK−1 is a vector with 1 in
the j-th element and 0 elsewhere. Here Vj represents a potential treatment choice. Since
this simplex is symmetric for all vertices, the angle between any pair of vertices Vj−1 and
Vj is the same.
Under this geometric framework, we utilize the angles between a (K − 1)-dimensional
classification function vector fm(Hm) =
(
fm,1(Hm), . . . , fm,K−1(Hm)
)
and V1,V2, ...,VK
to determine the decision rule at the m-th stage for 1 ≤ m ≤ mg. This decision rule follows
a principle which identifies the smallest angle. Specifically, the decision rule at the m-th
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Figure 1: Illustration of the angle-based approach with K = 3.
stage is defined as
Dm(Hm) = argmin
A∈{1,...,K}
Ang(VA,fm(Hm)) = argmax
A∈{1,...,K}
〈VA,fm(Hm)〉 , (3.11)
where Ang(VA,fm(Hm)) represents the angle between VA and fm(Hm). The last equality
in (3.11) follows from the fact that minimizing the angle between VA and fm(Hm) is
equivalent to maximizing the inner product between VA and fm(Hm). We let K = 3 as
an illustration example in Figure 1, where V1, V2, and V3 represent the three possible
treatment choices. Then the decision corresponding to the classification function fm in
Figure 1 is treatment 1, since the angle α1 between fm and V1 is the smallest among α1,
α2, and α3.
Substituting (3.11) for (3.10), then maximizing the function in (3.9) becomes a maxi-
mization problem of S¯D˜mg (tg) over fm. However, it is still challenging to maximize S¯D˜mg (tg)
directly, since S¯D˜mg (tg) is discontinuous with respect to fm for 1 ≤ m ≤ mg due to the
discontinuity of the indicator function in (3.10). Alternatively, a computationally more ef-
ficient approach is to replace the indicator by a continuous surrogate function. We consider
adopting logistic surrogate function
l(u) =
1
1 + e−b(u−u0)
, (3.12)
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which is a smooth and strictly increasing function, where the coefficient b > 0 measures
the steepness of the logistic curve and u0 ∈ R represents the inflection point. The choice
of the u0 will be discussed in Section 4.
We propose to replace I[Aim = Dim(Him)] with l
(〈
VAim ,fim(Him)
〉)
for 1 ≤ i ≤ N
and 1 ≤ m ≤ mg in (3.10). That is, the proposed estimator F̂ is the maximizer of the
following penalized log-transformed survival function
QN,tg(F ) = log
{
ŜD˜mg (t)
}
− Jλ(F ) = log
{
g∏
s=1
q̂D˜mg (s)
}
− Jλ(F )
=
g∑
s=1
log
{
1−
∑N
i=1wi(s− 1)I(Yi = ts)∆i∑N
i=1wi(s− 1)I(Yi ≥ ts)
}
− Jλ(F ), (3.13)
where
wi(s) =
∏m(ts)
j=1 l
(〈
VAij ,fj(Hj)
〉)
p̂(A˜im(ts)|Him(ts))
, (3.14)
F = (f1, . . . ,fmg), and Jλ(F ) is a penalty function on F with tuning parameter λ to
prevent overfitting and avoid the identifiability issue.
In Section 5, we present the implementation of the proposed method, and provide
the details for tuning the parameters λ, b, u0 and estimation of the propensity score
p̂(A˜im(ts)|Him(ts)) in (3.14).
4 Theory
In this section, we demonstrate the Fisher consistency (Liu 2007) of the proposed method,
indicating that the proposed estimator achieves the optimal DTR if the estimator is calcu-
lated using the entire population. Although the entire population is typically not observed
in practice, nevertheless the Fisher consistency shows that the proposed method is able to
predict the best treatment for each subject if we have sufficient information. Specifically,
we show that the DTR corresponding to the proposed estimator F¯ based on the entire pop-
ulation recommends the same treatments as the optimal D˜∗mg , where F¯ = (f¯1, . . . , f¯mg) is
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the maximizer of
Qtg(F ) =
g∑
s=1
log{q˜(s,F )} − λ
mg∑
j=1
sup
Hj
‖fj(Hj)‖2 (4.1)
over F =
{
F : fj is measurable and supHj ‖fj(Hj)‖2 < +∞ a.s., for 1 ≤ j ≤ mg
}
. Here,
we adopt a L2 penalty function and
q˜(s,F ) = 1−
E
[∏m(ts−1)
j=1 l
(〈
VAj ,fj(Hj)
〉)
I(Y = ts)∆
/{∏m(ts−1)
j=1 p(Aj|Hj)
}]
E
[∏m(ts−1)
j=1 l
(〈
VAj ,fj(Hj)
〉)
I(Y ≥ ts)
/{∏m(ts−1)
j=1 p(Aj|Hj)
}] . (4.2)
To simplify expression of the following conditions and theorem, we first define some
notations. Let A˜wc be a vector consisting of Aj for 1 ≤ j ≤ w − 1 and w + 1 ≤ j ≤ mg,
and
ϕ(tv(i), x˜w, aw, a˜wc) = E
A˜w
w+1
[
· · ·EA˜mg−1mg
{
P (T > tv(i)|X˜w = x˜w, Aw = aw, A˜wc = a˜wc)
}
· · ·
]
,
η1(X˜w, A˜wc , tv(i)) = min
aw 6=D∗w(Hw)
{
ci−wL ϕ(tv(i), X˜w,D∗w(Hw), A˜wc)− ϕ(tv(i), X˜w, aw, A˜wc)
}
,
η2(X˜w, A˜wc , i) = max
aw 6=D∗w(Hw)
{
c′U
c′L
ϕ(tv(i), X˜w,D∗w(Hw), A˜wc)− ci−wL ϕ(tv(i), X˜w, aw, A˜wc)
}
,
where EA˜m−1m represents an expectation with respect to {Xm | X˜m−1, A˜m−1} for w + 1 ≤
m ≤ mg; tv(i) is the first time-point at the i-th stage for 1 ≤ i ≤ mg, tv(mg+1) = tg; c′L and
c′U are the lower bound and upper bound of l
′(·), respectively; and cL is the lower bound
of l(·).
Condition 1. The l(·) in (4.2) is a strictly increasing surrogate function such that, l(0) > c¯
for some constant c¯ ∈ (0, 1/2], l(u) ∈ (0, 1) and l′′(u) < 0 for u ∈ (−|CQ|/λ, |CQ|/λ), where
CQ =
g∑
s=1
log
1− E
[∏m(ts−1)
j=1 I(Y = ts)∆
/{∏m(ts−1)
j=1 p(Aj|Hj)
}]
c¯ · E
[∏m(ts−1)
j=1 I(Y ≥ ts)
/{∏m(ts−1)
j=1 p(Aj|Hj)
}]
 .
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Condition 2. For each stage 1 ≤ w ≤ mg,
η1(X˜w, A˜wc , tg)−
mg∑
i=w+1
η−1 (X˜w, A˜wc , tv(i))−
mg∑
i=w
η+2 (X˜w, A˜wc , i)/κi > 0, (4.3)
where η+ and η− represent the positive part and negative part of η, respectively, and κi is
the lower bound of
∏mg
j=i+1 p(Aj|Hj) for 1 ≤ i ≤ mg − 1 with κmg = 1.
Condition 1 holds when the surrogate function l(·) is positive, strictly increasing, con-
cave, and bounded on a certain area, such as the logistic surrogate function in (3.12) with
u0 ≤ −|CQ|/λ. Condition 2 ensures that receiving the optimal individualized treatment at
each stage increases the targeted survival probability at the given time tg. It also ensures
that the increase in the survival probability at the given time t exceeds the changes of
survival probabilities at the beginning of stage 1 ≤ m ≤ mg.
Theorem 1. Under Conditions 1 and 2, we have
argmax
A∈{1,...,K}
〈
VA, f¯j(Hj)
〉
= D∗j (Hj) almost surely,
for stages j = 1, . . . ,mg.
Theorem 1 states that the proposed method is Fisher consistent, which is a fundamental
property for a classifier. Theorem 1 shows that the proposed method recommends the
optimal treatment for each subject at each stage with probability 1 if we obtain sufficient
data. To the best of our knowledge, this is the first Fisher consistency result for DTR
under the angle-based multicategory framework. The proof of the theorem is provided in
the supplementary material.
5 Implementation
In this section, we demonstrate how to solve the maximization problem with the objective
function QN,tg(θ) in (3.13) and how to select proper tuning parameters. Specifically, we
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consider that the classification functions are parametric models F (Hmg) = F (Hmg ,θ) and
we obtain an estimator θ̂ through maximizing QN,tg(θ) with a L2 penalty, that is,
θ̂ = arg max
θ
QN,tg(θ), (5.1)
where QN,tg(θ) = QN,tg(F (Hmg ,θ)) and the penalty part of QN,tg(θ) is Jλ(F (Hmg ,θ)) =
‖θ‖2. Here, we use the gradient descent algorithm to solve (5.1), and the explicit algorithm
can be summarized in the following table:
Implementation: Gradient descent algorithm
1. (Initialization) Input all observed {(Yi,∆i,Ximj , Aimj) : mj = 1, . . . ,mg}Ni=1, the
initial step size η0, initial value θ0, and a stopping criterion ε = 10
−4.
2. (Iteration) At the (k + 1)-th iteration (k ≥ 0), estimate θk+1 as follows
θ̂k+1 = θ̂k + ηk∇QN,tg(θ̂k),
where∇QN,tg(θ̂k) is the gradient value of QN,tg(θ) at θ̂k, and the step size ηk is chosen
by the Barzilai–Borwein method (Barzilai and Borwein 1988); that is,
ηk =
(θ̂k − θ̂k−1)>{∇QN,tg(θ̂k)−∇QN,tg(θ̂k−1)}
‖∇QN,tg(θ̂k)−∇QN,tg(θ̂k−1)‖2
.
3. (Stopping Criterion) Stop if max{‖θ̂k+1 − θ̂k‖2, |∇QN,tg(θ̂k+1) − ∇QN,tg(θ̂k)|2} < ε.
Otherwise go to step 2.
In practice, a proper choice of the parameters u0, b in (3.12) and λ in (3.13) could
enable our algorithm to estimate the optimal DTR. In particular, the choice of the tuning
parameter λ controls model complexity. We let u0 = −|CQ|/λ to satisfy Condition 1 for any
given b and λ. Various tuning techniques have been put forward in the existing literature.
Here we briefly discuss the d-fold cross-validation procedure, which is commonly used in
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practice. Specifically, all the samples are randomly partitioned into d equally sized subsets.
For each pair of tuning parameters (b, λ), we fit the model based on every d − 1 subsets,
and calculate the estimated survival function in (3.9) at the given time tg for the remaining
subset. Equivalently, the d − 1 subsets form a training set, while the remaining subset
serves as a validation set. We obtain a total of d training sets and d validation sets, and
choose the optimal tuning parameters which maximize the average of the estimated survival
probabilities over all of the validation sets. That is,
(̂b, λ̂)validated = argmax
(b,λ)
1
d
d∑
r=1
QrN,tg(θ̂|b, λ),
where θ̂ is the proposed estimator given b and λ using the r-th training set, and QrN,tg(θ̂|b, λ)
is the estimated survival probability at the given time tg based on θ̂ and the corresponding
validation set.
For data from an observational study, at the m-th stage (1 ≤ m ≤ mg), the propensity
scores P (Aim|Him) in (3.10) and (3.14) are unknown and thus need to be estimated. In
this paper, we use a penalized multinomial model to estimate the propensity scores. At the
m-th stage, we define β0k as the k-th intercept for k = 1, ..., K, and βpm×K as the pm ×K
coefficient matrix, where pm is the dimension of Hm. Let βk be the k-th column of βpm×K .
Then we model
P (Am = k|Hm) = exp(β0k + β
>
kHm)∑K
j=1 exp(β0j + β
>
jHm)
.
The log-likelihood function of this model is
log
[
L(
{
β0k,βk}K1
)]
=
1
N
N∑
i=1
{
K∑
k=1
I
(
Aim = k
) (
β0k +H
>
imβk
)− log( K∑
k=1
e(β0k+H
>
imβk)
)}
.
To obtain estimators for β0k and βk (1 ≤ k ≤ K), we minimize the penalized negative
log-likelihood:
min
{β0k,βk}K1
− log
[
L
({β0k,βk}K1 )]+ λ∗ K∑
k=1
‖βk‖1 ,
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where ‖ · ‖1 is the L1 norm, and λ∗ is the tuning parameter to control the overall strength
of the penalty and can be tuned by cross-validation.
6 Simulation Studies
In this section, we construct four simulation examples with both linear and non-linear clas-
sification functions to assess the finite sample performance of the proposed method. For all
examples, we compare the proposed method with the censored Q-learning method (Gold-
berg and Kosorok 2012) and the subgroup identification method (subgroup) (Huling and
Yu 2018). Since the censored Q-learning and subgroup methods can only handle binary
treatments, we extend these methods through the one-versus-rest approach to handle mul-
ticategory treatments for fair comparisons. Specifically, we conduct sequential 0-1 binary
treatment estimations, i.e., the treatment k versus others (k = 1, ..., K), using the censored
Q-learning and subgroup methods. If the k-th binary classifier recommends 1, then the
treatment k will be selected as the recommended treatment. For the subgroup method,
since it is only designed to estimate the optimal decision rule at a single stage, we use it to
recommend the optimal treatment at each single stage separately, and then combine the
recommended treatments together as the recommended sequential treatments. We assess
the performance of these methods via the estimated conditional survival probability under
each estimated DTR as defined in (3.9).
We generate data (Yi, Ci, Ti,∆i,Xim, Aim) for i = 1, . . . , N and m = 1, . . . ,M , where
M is the number of total stages, Xim consists of p covariates for the i-th patient at the
m-th stage, and Aim is the treatment assigned to the i-th patient at the m-th stage. For
all of our simulation examples, we consider p = 25, M = 5, and three potential treatment
choices {1, 2, 3}. We first generate a training set with the sample size of 500 for the model
fitting, and then we simulate an independent testing set with 2000 observations to evaluate
the model performance. We consider three different censoring rates, and specify two target
time-points tg = 1.4 and 2.1 which correspond to the 3rd and 5-th stages, respectively.
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We perform simulations 150 times and report the average values of estimated conditional
survival probabilities. We also provide boxplots under the three different censoring rates
for evaluation of the numerical performance. The details of each setting are described as
follows:
Example 1: In this example, we let the underlying sequential decision rule dim and
the true assigned treatment Aim both follow an independent discrete Uniform{1, 2, 3} dis-
tribution for 1 ≤ i ≤ n and 1 ≤ m ≤ 5. We also let c1m = (0.5m, 0, 0, ..., 0), c2m =
(0, 0.5m, 0, ..., 0), and c3m = (0, 0, 0.5m, 0, ..., 0) be three p-dimensional vectors. We gener-
ate covariates Xim from a multivariate normal distribution N (cjm, 0.1Ip), where Ip is a p
dimensional identity matrix, and j = dim. The true survival time for each subject is
Ti = exp
{
M∑
m=1
0.5I(Aim = dim)− 3Xi15 +X3i22 − |Xi33|+ 1i
}
,
and the censoring time is Ci = exp (0.5
2
2i − 2i + 3i − 224i + c0), where ri (r = 1, 2, 3, 4)
are generated from an independent normal distribution N (0, 1), and c0 is a constant added
to control the censoring rate.
Example 1 is designated to evaluate the numerical performance of the proposed method
when the decision rules are relatively simple and have immediate treatment effects. Note
that although the decision rules dim are uniformly generated, the covariatesXim are related
to the decision rule since the mean of Xim depends on dim. According to Figures 2 and 3,
the proposed method performs much better than the competing methods at both stages 3
and 5. Also, Table 1 shows that under the 74% censoring rate and tg = 2.1, the proposed
method yields 35.3% and 16.6% improvement compared to the censored Q-learning and
subgroup methods, respectively, in terms of the conditional survival probabilities. This
implies that the proposed method is a better performer when the underlying sequential
decision rules have a relatively simple form.
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Table 1: Example 1: The estimated conditional survival probability S¯D̂(tg) with standard deviations (SD)
in parentheses based on 150 simulations. “Imp-rate” represents the improvement rate of the proposed
method compared to other methods.
Stage tg Censoring Rate Method S¯
D̂(tg)(SD) Imp-rate
3 1.4 74% Proposed 0.674(0.072) –
Qlearning 0.539(0.080) 24.9%
Subgroup 0.591(0.087) 14.0%
5 2.1 74% Proposed 0.586(0.142) –
Qlearning 0.433(0.186) 35.3%
Subgroup 0.503(0.153) 16.6%
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Figure 2: Example 1: Boxplots of the esti-
mated conditional survival probabilities at
the third stage for different censoring rates.
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Figure 3: Example 1: Boxplots of the esti-
mated conditional survival probabilities at
the fifth stage for different censoring rates.
Example 2: For the i-th subject at the m-th stage, the decision rule dim is determined
by the following classification function vector
fm(Him) = (f1m(Him), f2m(Him))
>=
(
H>imθm1,H
>
imθm2
)>
.
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The dim is defined as
dim = argmin
k∈{1,2,3}
Ang{fm(Him),Vk}.
Let θ1j = θj
>, θ2j = (0.5θj,−1.5θj, 0.1)>, θ3j = (0.25θj,−0.5θj,θj, 0.05, 0.1)>, θ4j =
(0.1θj,−0.25θj, 0.5θj,θj, 0.01,−0.05, 0.1)>, and θ5j = (0.05θj,−0.1θj, 0.25θj, 0.5θj,θj, 0.01,
−0.05, 0.05,−0.1)> for j = 1, 2, where θ1 = (1, 1, 1, 0, ..., 0) and θ2 = (1,−1,−1, 0, ..., 0)
are both p-dimensional vectors. We generate covariates Xim from a multivariate nor-
mal distribution N (0, Ip). The assigned treatment Aim follows an independent discrete
Uniform{1, 2, 3} distribution. The true survival time for the i-th subject is
Ti = exp
{
M∑
m=1
0.75I(Aim = dim)− 0.5|Xi15|+Xi12 + 1i
}
,
and the censoring time is Ci = exp (0.52i + 3i − 4i + c0), where ri (r = 1, 2, 3, 4) are
generated from the independent normal distribution N (0, 1), and c0 is a constant added to
control the censoring rate.
Example 2 represents a case with linear classification functions and angle-based decision
rules, which is more complex than Example 1 where decision rules are randomly generated.
In this situation, the proposed method can still outperform the competing methods. Ac-
cording to Table 2, when tg = 2.1 with 66% censoring rate, the improvement rates of the
proposed method are 33.9% and 29.1% compared to the censored Q-learning and the sub-
group methods, respectively. In contrast to the subgroup method, which only incorporates
patients’ information from a single stage to estimate the optimal decision rule for that
stage, the propose method utilizes information from all sages, and can thus achieve bet-
ter performance. In addition, the improvement of the proposed method compared to the
censored Q-learning method is likely because the proposed method can directly estimate
all decision rules simultaneously. Yet the censored Q-learning method recursively models
the relationship between the survival time and covariates for measuring treatment effects,
which requires an additional step of fitting the model and could cause bias under the model
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misspecification.
Table 2: Example 2: The estimated conditional survival probability S¯D̂(tg) with standard deviations (SD)
in parentheses based on 150 simulations. “Imp-rate” represents the improvement rate of the proposed
method compared to other methods.
Stage tg Censoring Rate Method S¯
D̂(tg)(SD) Imp-rate
3 1.4 61% Proposed 0.857(0.071) –
Qlearning 0.660(0.057) 29.8%
Subgroup 0.687(0.069) 24.7%
5 2.1 66% Proposed 0.731(0.097) –
Qlearning 0.546(0.108) 33.9%
Subgroup 0.566(0.137) 29.1%
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Figure 4: Example 2: Boxplots of the esti-
mated conditional survival probabilities at
the third stage for different censoring rates.
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Figure 5: Example 2: Boxplots of the esti-
mated conditional survival probabilities at
the fifth stage for different censoring rates.
Example 3: We follow the same setting as the one in Example 2, except that we do
not make the distribution of Aim follow a uniform distribution. In particular, we specify
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the true propensity score as follows:
P (Aim = 3|Him) =
(
1 +
2∑
j=1
exp(Him
>γjm)
)−1
and P (Aim = k|Him) = exp(Him
>γkm)
1 +
∑2
j=1 exp(Him
>γjm)
,
where k = 1, 2, m = 1, ....5, γjm = (γj, ...,γj,0m−1)>, which includes m copies of p-
dimensional vector γj with γ1 = (0, 0, 0.25, 0, ..., 0) and γ2 = (0,−0.25, 0.5, 0, ..., 0), and
(m− 1)-dimensional zero vector 0m−1.
In Example 3, to mimic observational studies, the treatments are not uniformly assigned
and the probabilities corresponding to treatment assignments (the propensity scores) are
unknown. We utilize the penalized multinomial model proposed in Section 5 to estimate
the propensity scores. Table 3 and Figure 6-7 indicate that the proposed method still leads
to larger estimated conditional survival probabilities than the two existing methods. The
improvement rates compared to the censored Q-learning and subgroup method are about
28.5% and 23.1%, respectively, for tg = 1.4.
Table 3: Example 3: The estimated conditional survival probability S¯D̂(tg) with standard deviations (SD)
in parentheses based on 150 simulations. “Imp-rate” represents the improvement rate of the proposed
method compared to other methods.
Stage tg Censoring Rate Method S¯
D̂(tg)(SD) Imp-rate
3 1.4 61% Proposed 0.846(0.078) –
Qlearning 0.659(0.057) 28.5%
Subgroup 0.688(0.063) 23.1%
5 2.1 66% Proposed 0.728(0.122) –
Qlearning 0.570(0.116) 27.6%
Subgroup 0.567(0.138) 28.3%
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Figure 6: Example 3: Boxplots of the esti-
mated conditional survival probabilities at
the third stage for different censoring rates.
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Figure 7: Example 3: Boxplots of the esti-
mated conditional survival probabilities at
the fifth stage for different censoring rates.
Example 4: In this example, we let f1m(Him) = (H
>
imθm1)
3 and f2m(Him) = (H
>
imθm2)
3
for 1 ≤ i ≤ n and 1 ≤ m ≤ 5. Also, we let θ1j = θj>, θ2j = (−0.5θj,θj,−0.3)>, θ3j =
(0.25θj,−0.25θj, 1.5θj,−0.05,−0.1)>, θ4j = (0.25θj,−0.25θj,−0.25θj,θj, 0.05, 0.05,−0.15)>,
and θ5j = (0.05θj,−0.1θj,−0.25θj,−0.5θj,θj, 0.05,−0.05, 0.05,−0.1)> for j = 1, 2, where
θ1 = (−1, 0.5,−1, 0, ..., 0) and θ2 = (0.5,−1,−1, 0, ..., 0) are p-dimensional vectors. The
decision rule dim is defined as
dim =

1 +
[
sgn{f1m(Him)}
]+
+
[
sgn{f2m(Him)}
]+
, with probability 0.95,
Ui, with probability 0.05,
where Ui follows a discrete Uniform{1, 2, 3} distribution independent of (Aim,Xim), and[
sgn{f1m(Him)}
]+
and
[
sgn{f2m(Him)}
]+
represent the positive parts of sgn{f1m(Him)}
and sgn{f2m(Him)}, respectively. Each covariate in Xim follows a continuous uniform dis-
tribution U(0, 1). The assigned treatmentAim follows an independent discrete Uniform{1, 2, 3}
24
distribution. The true survival time for the i-th subject is
Ti = exp
{
M∑
m=1
0.5I(Aim = dim)− 2|Xi13|+Xi15 + 1i
}
,
and the censoring time is Ci = exp (0.5|2i|+ 3i + 4i + c0), where 1i is generated from
a normal distribution N (0, 1), ri (r = 2, 3, 4) are generated from continuous uniform
distribution U(0, 1), and c0 is a constant added to control the censoring rate.
In Example 4, we include non-linear classification functions, and intentionally add some
outliers into the samples to evaluate the robustness of the proposed method. Although
all the methods could be affected by the outliers, the proposed method still performs
better than the other methods. According to Table 4, the proposed method outperforms
the subgroup and the censored Q-learning methods with improvement rates of 19.4% and
130.4%, respectively, for tg = 2.1. Note that the censored Q-learning method performs much
worse in this example than in other examples in terms of the estimated conditional survival
probabilities, which indicates that the censored Q-learning method is not appropriate for
data based on non-linear classification functions. This may be because the censored Q-
learning method is not robust to the non-linear classification functions and the outliers.
Table 4: Example 4: The estimated conditional survival probability S¯D̂(tg) with standard deviations (SD)
in parentheses based on 150 simulations. “Imp-rate” represents the improvement rate of the proposed
method compared to other methods.
Stage tg Censoring Rate Method S¯
D̂(tg)(SD) Imp-rate
3 1.4 72% Proposed 0.752(0.071) –
Qlearning 0.384(0.101) 96.0%
Subgroup 0.679(0.096) 10.9%
5 2.1 72% Proposed 0.659(0.165) –
Qlearning 0.286(0.173) 130.4%
Subgroup 0.552(0.185) 19.4%
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Figure 8: Example 4: Boxplots of the esti-
mated conditional survival probabilities at
the third stage for different censoring rate
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Figure 9: Example 4: Boxplots of the esti-
mated conditional survival probabilities at
the fifth stage for different censoring rate
In summary, the results from the four examples indicate that the proposed method pro-
duces better predictions than the competing methods. In addition, Figures 4-9 show that
the improvement of the performance from the proposed method increases as the censoring
rate increases. This implies that the proposed method can achieve better numerical perfor-
mance and estimate the optimal dynamic treatment regime more accurately under a high
censoring rate. One possible reason is that the proposed method utilizes more information
by incorporating patients’ information from all stages instead of from only one single stage.
For the case of a single decision point, model-based indirect methods such as the censored
Q-learning may be efficient if the posited regression model is correctly specified. However,
in the multistage setting, the verification of true model specification for the survival time
might be infeasible for all stages, and thus the censored Q-learning is likely to fail due to
model misspecification. Instead, the proposed method circumvents this problem by avoid-
ing modeling the relationship between the survival time and covariates, and estimates the
optimal dynamic treatment regime directly.
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7 Real Data Examples
In this section, we apply the proposed method to the Framingham heart study data and
acquired immunodeficiency syndrome (AIDS) clinical data for assessing its performance.
The proposed method is implemented with linear classification functions. For comparison,
we consider the censored Q-learning method (Goldberg and Kosorok 2012) and the sub-
group identification method (Huling and Yu 2018) with one-versus-rest extension, the same
as in Section 6.
7.1 Application to Framingham Heart Study Data
The Framingham heart study, established in 1948, is the first longitudinal prospective large-
scale cohort to study cardiovascular disease in the United States. The epidemiological and
genetic risk factors for cardiovascular disease are investigated by monitoring original cohort
participants. According to Tsao and Vasan (2015), up to 32 examinations are performed
for each individual biannually during the 65 years of follow-up. Here we only utilize par-
ticipants’ information from the second visit to the sixth visit, where each visit represents
one stage, and different participants can have different numbers of visits. Typically, an
antihypertensive treatment will be recommended to individual participants based on the
level of blood pressure. Nevertheless, the accuracy of recommendation may be potentially
improved if we take more information about participants into account, so that the overall
survival probability of cardiovascular disease could be improved. In this study, we aim to
maximize the overall survival probability of cardiovascular disease by customizing sequen-
tial decision rules which inform each participant whether an antihypertensive treatment
should be taken to balance the blood pressure level at each decision point.
Specifically, we obtain participants’ observed survival time (Yi), death reviewed status
(∆i), visit time, and whether to take the antihypertensive treatment (Aim = 0 or 1) at
each visit m from the data. In our analysis, we incorporate the following information as
covariates (Xim) collected at each visit: age, cholesterol, high-density lipoprotein, diastolic
27
blood pressure, and the presence of diabetes. There are a total of 3939 participants who
have completely observed covariates at each visit before Yi, that is, n = 3939. The death
event rate is 22.9% by the end of the study. We randomly select 1000 participants as a
training set and the other 1000 participants as a testing set for 50 iterations. We consider
four target time-points tg = 4775, 5946, 7376 and 8539, and calculate the estimated condi-
tional survival probability at each tg for each testing set given the recommended sequential
decision rules estimated on the corresponding training set.
The average values of the estimated conditional survival probabilities and the corre-
sponding boxplots are presented in Table 5 and Figure 10, respectively. Table 5 and Figure
10 show that the proposed method achieves the highest survival probabilities at all different
target time-points. The improvements of the proposed method compared to the censored
Q-learning method and subgroup method are both more than 5%. Notice that as the
number of stages increases, the proposed method improves even more than the competing
methods. This is possibly due to the fact that the proposed method integrates information
from all stages into one single algorithm, which is more effective than the methods only
considering information from one single stage information at a time.
Table 5: The estimated conditional survival probability S¯D̂(tg) with standard deviations (SD) in parenthe-
ses based on 50 simulations. “Imp-rate” represents the improvement rate of the proposed method compared
to other methods.
Stage tg Method S¯
D̂(tg)(SD) Imp-rate
3 4775 Proposed 0.988(0.002) –
Qlearning 0.881(0.012) 12.1%
Subgroup 0.931(0.006) 6.1%
4 5946 Proposed 0.940(0.014) –
Qlearning 0.888(0.008) 5.9%
Subgroup 0.895(0.009) 5.0%
5 7376 Proposed 0.911(0.024) –
Qlearning 0.684(0.062) 33.2%
Subgroup 0.790(0.012) 15.3%
6 8539 Proposed 0.802(0.047) –
Qlearning 0.533(0.038) 50.5%
Subgroup 0.685(0.019) 17.1%
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Figure 10: Boxplot of the estimated conditional survival probabilities based on 50 simulation runs.
7.2 Application to AIDS Clinical Data
In this subsection, we apply the proposed method to data from the AIDS Clinical Trials
Group (ACTG) 175 (Hammer et al. 1996). ACTG 175 is a double-blind and randomized
clinical trial, which uses the counts of CD4+ T cells of patients to compare monothera-
pies and combination therapies of HIV infection. In this trial, 2139 patients (n = 2139)
with HIV infection were randomly assigned to four treatment groups (K = 4) with the
same probability: zidovudine (ZDV) monotherapy, ZDV and didanosine (ddI), ZDV and
zalcitabine (ZAL), and ddI monotherapy. We obtain information regarding whether events
happen or not for a patient (∆i), and the observed time (Yi) when patients are censored or
events occur. Here, an event refers to the patient’ death, a decline of CD4+ T cell counts
being at least 50, or an event indicating progression to AIDS. In addition to the treatment
and event time, we consider 12 clinical covariates (p = 12) in our analysis, which are also
included in (Fan et al. 2017) and (Qi and Liu 2018). Five of the 12 covariates are continu-
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ous: weight, CD4+ T cells counts at baseline, CD8 count at baseline, age, and Karnofsky
score, where Karnofsky score is a way to rate a person’s ability to perform activities of daily
living, and ranges from 0 to 100, with a higher score indicating that a person is more able
to perform daily activities. The remaining seven covariates are binary: gender (0=female,
1=male), race (0=white, 1=non-white), homosexual activity (0 = no, 1 = yes), history
of intravenous drug use (0=no, 1=yes), symptomatic status (0=asymptomatic, 1=symp-
tomatic), antiretroviral history (0=naive, 1=experienced), and hemophilia (0=no, 1=yes).
This study only involves one decision point (one stage), but with multicategory treat-
ments which contain four different treatment choices. Similarly as in Subsection 7.1, we
randomly select 1000 participants as a training set and the other 1000 participants as a
testing set for 50 iterations. We specify three target time-points tg = 861, 984 and 1169,
and calculate the estimated conditional survival probability at each tg for each testing set
given the recommended sequential decision rules estimated on the corresponding training
set.
Table 6 and Figure 11 show that the proposed method achieves the highest survival
probabilities at all target time-points. Notice that as the tg increases, the proposed method
has improved more compared to the competing methods. Although there is only one stage
for treatment decision, the higher survival probabilities of the proposed method still indicate
that patients would receive more long-term benefits if the proposed strategy is applied.
30
Table 6: The estimated conditional survival probability S¯D̂(tg) with standard deviations (SD) in parenthe-
ses based on 50 simulations. “Imp-rate” represents the improvement rate of the proposed method compared
to other methods.
tg Method S¯
D̂(tg)(SD) Imp-rate
861 Proposed 0.779(0.050) –
Qlearning 0.774(0.046) 0.65%
Subgroup 0.753(0.071) 3.45%
984 Proposed 0.823(0.052) –
Qlearning 0.709(0.050) 1.97%
Subgroup 0.702(0.069) 2.99%
1169 Proposed 0.695(0.055) –
Qlearning 0.669(0.057) 3.89%
Subgroup 0.671(0.069) 3.58%
0.5
0.6
0.7
0.8
0.9
861 984 1169
t
pr
ob
Method
Proposed
Qlearning
Subgroup
Figure 11: Boxplot of the estimated conditional survival probabilities based on 50 simulation runs.
8 Discussion
In this paper, we propose a novel weighted Kaplan-Meier estimator to estimate the survival
function for patients following a specific DTR, and propose an objective function based on
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this weighted Kaplan-Meier estimator under an angle-based framework for multicategory
treatments. We estimate the optimal DTR through maximizing the proposed objective
function. In this way, we formulate the estimations of decision rules at multiple stages as
an unconstrained optimization problem. Therefore, the proposed method is more compu-
tationally efficient than the multicategory methods with the sum-to-zero constraint. Also,
the proposed method avoids a potential model-misspecification problem which commonly
arises in fitting the regression model to one stage based on estimations of regression models
at other stages. Moreover, the proposed method can be easily extended to incorporate
some other multicategory classification approaches due to its flexibility.
Several improvements and extensions are worth exploring in the future. Although the
proposed method is implemented for a linear classification function based on a linear com-
bination of prior information in this paper, we can also extend our method to estimate
non-linear classification functions by applying Gaussian kernel learning classifiers. In ad-
dition, the goal of the proposed method is to search for the optimal DTR for maximizing
conditional survival probability, which can be potentially generalized to obtain DTRs that
maximize other outcomes of interests, e.g., mean residual life and median survival time.
Additionally, developing statistical inference for prediction is also useful in practice,
e.g., generalizing our method to quantify uncertainty via confidence interval and hypoth-
esis testing. Moreover, the proposed method is based on an inverse probability weighting
procedure, which is potentially less efficient since it only utilizes information of patients
who received treatments following a given DTR. To incorporate information of patients who
do not follow a given DTR, a potential generalization of the proposed method could be
based on augmented inverse probability weighting (Zhang et al. 2013). Furthermore, it is
important to extend the proposed method for continuous treatments, such as drug dosages,
to improve clinical practice and enhance personalized medicine treatment for patients.
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